Fuchs Endothelial Corneal Dystrophy Clinical Trials
2 recruiting trials for Fuchs Endothelial Corneal Dystrophy. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Fuchs Endothelial Corneal Dystrophy clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Instituto Ramón y Cajal de Investigación Sanitaria (1), Eye & ENT Hospital of Fudan University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Phacoemulsification Cataract Surgery (procedure, 1 trial).
Track Fuchs Endothelial Corneal Dystrophy trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
SUCCESS Score Validation in Fuchs Dystrophy
This prospective multicenter diagnostic study aims to externally validate and extend the SUCCESS Score for predicting the need for endothelial keratoplasty after cataract surgery...
Comparison of Outcomes Between Femtosecond Laser-Assisted and Conventional Phacoemulsification in Fuchs Endothelial...
The goal of this observational study is to compare the mid- to long-term efficacy of femtosecond laser-assisted cataract surgery (FLACS) and conventional phacoemulsification...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Fuchs Endothelial Corneal Dystrophy, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Fuchs Endothelial Corneal Dystrophy, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Fuchs Endothelial Corneal Dystrophy, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.